Cargando…

Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party

We investigated ≥ grade 3 (CTC-AE) organ toxicities for commercial CD19 chimeric antigen receptor T cell (CAR-T cell) products in 492 patients (Axi-Cel; n = 315; Tisa-Cel; n = 177) with Large B-cell Lymphoma in the European Society for Blood and Marrow Transplantation (EBMT) CAR-T registry. The inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Penack, Olaf, Peczynski, Christophe, Koenecke, Christian, Polge, Emmanuelle, Sanderson, Robin, Yakoub-Agha, Ibrahim, Fegueux, Nathalie, Daskalakis, Michael, Collin, Matthew, Dreger, Peter, Kröger, Nicolaus, Schanz, Urs, Bloor, Adrian, Ganser, Arnold, Besley, Caroline, Wulf, Gerald G., Novak, Urban, Moiseev, Ivan, Schoemans, Hélène, Basak, Grzegorz W., Chabannon, Christian, Sureda, Anna, Glass, Bertram, Peric, Zinaida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565347/
https://www.ncbi.nlm.nih.gov/pubmed/37828980
http://dx.doi.org/10.3389/fimmu.2023.1252811